Stock listing
NASDAQ:AUXL Auxilium Pharmaceuticals Inc Stock
Follow Auxilium Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:AUXL
$36.47 USD
Close on Jan 29, 2015 · No longer trades
- Lowest – highest close
- $3.90 – $42.35 USDSince Jul 23, 2004 · lowest Oct 31, 2005 · highest Aug 13, 2008
Delisted NASDAQ:AUXL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AUXL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Auxilium Pharmaceuticals Inc on 6ix
- Decks
- 74 decks · latest Dec 3, 2014
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (December 2014) | Merger or acquisition | 20 slides | Dec 3, 2014 |
| Q3 2014 Earnings Presentation | Earnings | 26 slides | Nov 5, 2014 |
| Merger or Acquisition (November 2014) | Merger or acquisition | 15 slides | Nov 5, 2014 |
| Merger or Acquisition (October 2014) | Merger or acquisition | 15 slides | Oct 15, 2014 |
| Merger or Acquisition (October 2014) | Merger or acquisition | 10 slides | Oct 10, 2014 |
| Merger or Acquisition (October 2014) | Merger or acquisition | 16 slides | Oct 9, 2014 |
| Merger or Acquisition (September 2014) | Merger or acquisition | 13 slides | Sep 16, 2014 |
| Morgan Stanley Healthcare Conference 2014 | Conference | 36 slides | Sep 10, 2014 |
| Q2 2014 Earnings Presentation | Earnings | 31 slides | Aug 7, 2014 |
| Q2 2013 Earnings Presentation | Earnings | 28 slides | Aug 1, 2013 |
Show 50 decks
This page holds 50 of 74 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adrian Adams Other companies: Akebia Therapeutics, Inc. (Chairperson · Since at least Dec 12, 2018); Talphera, Inc. (Director · Since at least Feb 11, 2013); Impel Neuropharma Inc (COB, CEO and President, Director · Apr 22, 2021 – Jan 26, 2022 · Past); Aralez Pharmaceuticals Inc (Chief Executive Officer, Director · Feb 5, 2016 – May 11, 2017 · Past); POZEN Inc (Chief Executive Officer, Director · May 31, 2015 – Nov 11, 2015 · Past); Inspire Pharmaceuticals Inc (President and CEO, Director · Feb 22, 2010 – May 13, 2011 · Past); Amylin Pharmaceuticals LLC (Director · Oct 29, 2007 – Aug 8, 2012 · Past); Sepracor Inc (President & CEO, Director · Mar 1, 2007 – Oct 20, 2009 · Past); Neurocrine Biosciences, Inc. (Director · Jun 30, 2006 – Jun 30, 2006 · Past); Kos Pharmaceuticals Inc (President & CEO, Director · Jan 26, 2006 – Dec 13, 2006 · Past) | CEO and President, Director · Dec 7, 2011 – Jan 29, 2015 · Past |
| Paul A. Friedman Other companies: Prelude Therapeutics Incorporated (Chair · Since at least Mar 27, 2020); Madrigal Pharmaceuticals, Inc. (Director · Since at least Mar 3, 2014); Alexion Pharmaceuticals Inc (Director · Sep 14, 2017 – Jul 21, 2021 · Past); Verastem, Inc. (Director · May 12, 2014 – Jun 14, 2016 · Past); Dare Bioscience, Inc. (Director · Apr 10, 2014 – Apr 3, 2017 · Past); Durata Therapeutics Inc (Director · May 16, 2013 – Nov 17, 2014 · Past); Sirtris Pharmaceuticals Inc (Director · Mar 24, 2008 – Apr 16, 2008 · Past); Incyte Corporation (Director · Jan 13, 2006 – May 26, 2020 · Past) | Director · Jun 3, 2010 – Jan 29, 2015 · Past |
| Andrew Koven Other companies: MetaVia Inc. (Chairman of the Board · Since at least Jul 9, 2021); Kala Bio, Inc. (Director · Since at least Sep 28, 2017); Aralez Pharmaceuticals Inc (President & Chief Business Off · Feb 5, 2016 – Jun 4, 2018 · Past); POZEN Inc (President, Chief Business Ofc. · May 31, 2015 – Jun 3, 2015 · Past); Inspire Pharmaceuticals Inc (EVP & Chief Admin & Legal Ofc · May 10, 2010 – May 13, 2011 · Past); Sepracor Inc (Exec VP, General Counsel · Mar 1, 2007 – Oct 20, 2009 · Past); Kos Pharmaceuticals Inc (EVP, General Counsel · Jan 26, 2006 – Dec 13, 2006 · Past) | EVP, CAO, GC and Secretary · Feb 3, 2012 – Jan 29, 2015 · Past |
| Mark A. Glickman Other companies: BioStem Technologies, Inc. (Director · Since at least Aug 6, 2026); MetaVia Inc. (Independent Director · Since at least May 11, 2023); TherapeuticsMD, Inc. (Co-Chief Executive Officer · Oct 15, 2021 – Dec 6, 2022 · Past); Esperion Therapeutics, Inc. (Chief Commercial Officer · Dec 20, 2018 – Jan 2, 2020 · Past); Aralez Pharmaceuticals Inc (Chief Commercial Officer · Feb 5, 2016 – Mar 19, 2018 · Past); POZEN Inc (Chief Commercial Officer · Jun 22, 2015 – Jun 22, 2015 · Past) | EVP - Sales and Marketing · Feb 3, 2012 – Jan 29, 2015 · Past |
| William McKee Other companies: Assertio Holdings, Inc. (Director · Since at least May 19, 2020); C4 Therapeutics, Inc. (Chief Financial Officer · Oct 1, 2020 – Oct 6, 2020 · Past); Rein Therapeutics, Inc. (Director · Jun 19, 2019 – Jun 15, 2022 · Past); Depomed Inc (Director · Mar 28, 2017 – May 8, 2018 · Past); Dare Bioscience, Inc. (Director · Apr 10, 2014 – Jan 3, 2017 · Past); Barr Pharmaceuticals Inc (EVP, CFO · Jan 3, 2006 – Dec 23, 2008 · Past) | Director · Mar 18, 2009 – Jan 29, 2015 · Past |
| Andrew Saik Other companies: Milestone Pharmaceuticals Inc. (Independent Non-Executive Director · Since at least Jul 15, 2024); Arvinas, Inc. (Chief Financial Officer and Treasurer · Since at least Jun 24, 2024); Intercept Pharmaceuticals Inc (EVP & Chief Financial Officer · Jun 21, 2021 – Nov 8, 2023 · Past); VYNE Therapeutics Inc. (Chief Financial Officer · Sep 8, 2020 – May 28, 2021 · Past); PDS Biotechnology Corporation (Chief Financial Officer, Director · Oct 31, 2017 – Feb 14, 2020 · Past) | CFO · Aug 18, 2014 – Jan 29, 2015 · Past |
| Armando Anido Other companies: Scynexis, Inc. (Director · Since at least Jan 21, 2019); Vaxart, Inc. (Director · Sep 21, 2015 – May 18, 2017 · Past); Zynerba Pharmaceuticals Inc (Chairman & Chief Exec. Officer, Director · Aug 4, 2015 – Oct 10, 2023 · Past); NuPathe Inc. (Chief Executive Officer, Director · Jul 25, 2012 – Feb 21, 2014 · Past); Adolor Corp (Director · May 18, 2010 – Dec 7, 2011 · Past) | CEO & President, Director · Apr 12, 2010 – Oct 7, 2011 · Past |
| James P. Tursi Other companies: MetaVia Inc. (Independent Director · Since at least Nov 1, 2023); Endo International PLC (Executive VP, Global R&D · Feb 24, 2022 – Jul 15, 2022 · Past); Antares Pharma Inc (EVP, Chief Medical Officer · Aug 6, 2018 – Jun 13, 2019 · Past); Aralez Pharmaceuticals Inc (Chief Medical Officer · Feb 5, 2016 – May 14, 2018 · Past); POZEN Inc (Chief Medical Officer · Oct 1, 2015 – Oct 1, 2015 · Past) | Chief Medical Officer · Feb 14, 2012 – Jan 29, 2015 · Past |
| Jennifer Evans Stacey Other companies: Neogen Corporation (Chief Legal Officer · Since at least Apr 8, 2026); Context Therapeutics Inc. (Independent Director · Since at least Oct 19, 2021); Galera Therapeutics, Inc. (See Remarks · Oct 8, 2021 – Feb 25, 2023 · Past); Antares Pharma Inc (SVP, General Counsel & Secty · May 29, 2014 – May 28, 2015 · Past) | Executive VP & General Counsel · Jun 6, 2006 – Feb 28, 2011 · Past |
| Alfred Altomari Other companies: Recro Pharma Inc (Director · Mar 12, 2014 – Dec 5, 2019 · Past); Insmed Incorporated (Director · Aug 2, 2012 – May 13, 2024 · Past); Barrier Therapeutics Inc (Chief Executive Officer, Director · Mar 31, 2006 – Aug 5, 2008 · Past) | Director · Jun 6, 2006 – Jun 16, 2011 · Past |
All 24 people
| Person | Seat |
|---|---|
| Geraldine Henwood Other companies: Tetraphase Pharmaceuticals Inc (Director · Apr 15, 2015 – Jun 10, 2019 · Past); Recro Pharma Inc (Director · Mar 6, 2014 – Apr 20, 2021 · Past); Alkermes plc (Director · Sep 21, 2006 – May 28, 2014 · Past) | CEO and Interim President, Director · Mar 10, 2006 – Jun 23, 2006 · Past |
| Oliver Fetzer Other companies: Arena Pharmaceuticals Inc (Director · Feb 13, 2017 – Mar 11, 2022 · Past); Dare Bioscience, Inc. (President and CEO, Director · Apr 10, 2014 – Oct 29, 2014 · Past); Cubist Pharmaceuticals Inc (Senior Vice President · Jan 9, 2006 – Sep 14, 2007 · Past) | Director · Jun 6, 2006 – Jan 29, 2015 · Past |
| Peter Brandt Other companies: IN8bio, Inc. (Director · Since at least Jul 29, 2021); Epocrates Inc (Director · Jan 31, 2011 – Mar 12, 2013 · Past); Opus Genetics, Inc. (Director · Sep 9, 2010 – Jun 6, 2019 · Past) | Director · Dec 16, 2010 – Jan 29, 2015 · Past |
| Elizabeth Varki Jobes Other companies: Blue Foundry Bancorp (Director · Since at least Dec 29, 2022); Ampio Pharmaceuticals, Inc. (Director · Feb 8, 2022 – Mar 1, 2022 · Past) | Chief Compliance Officer · Apr 19, 2012 – Jan 29, 2015 · Past |
| James E Fickenscher Other companies: Zynerba Pharmaceuticals Inc (Chief Financial Officer · Sep 13, 2016 – Oct 10, 2023 · Past); Antares Pharma Inc (Senior Vice President & CFO · Nov 17, 2014 – Jun 2, 2016 · Past) | Chief Financial Officer · Mar 10, 2006 – Jun 21, 2014 · Past |
| Roger D Graham Jr Other companies: Adolor Corp (SVP Sales & Marketing · Jan 6, 2006 – Jan 6, 2006 · Past) | EVP, Sales & Marketing · Mar 19, 2007 – Feb 28, 2011 · Past |
| Alan Wills | EVP, Corporate Development · Feb 7, 2013 – Jan 29, 2015 · Past |
| Anthony DelConte | Chief Medical Officer · Jan 31, 2008 – Mar 12, 2010 · Past |
| Benjamin J Del Tito Jr | EVP, Reg Affairs & Project Mgt · Feb 14, 2012 – Mar 14, 2014 · Past |
| Dennis J Purcell | Director · Jun 13, 2007 – Jun 12, 2008 · Past |
| Edward F Kessig | Senior Vice President, Sales · Mar 10, 2006 – Nov 1, 2011 · Past |
| Edward J Arcuri | EVP, Technical Operations · Jul 26, 2010 – Feb 17, 2011 · Past |
| Edwin A Bescherer Jr | Director · Jun 6, 2006 – Jun 3, 2010 · Past |
| Renato Fuchs | Director · Jun 13, 2007 – Mar 30, 2012 · Past |
Log in to ask 6ix AI your own questions about Auxilium Pharmaceuticals Inc.